Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 46

    1.

    Accelerated venovenous hemofiltration: early technical and clinical experience.

    Gashti CN, Salcedo S, Robinson V, Rodby RA.

    Am J Kidney Dis. 2008 May;51(5):804-10. Epub 2008 Mar 25.PMID: 18436091 [PubMed - indexed for MEDLINE]Related articles

    2.

    A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA.

    Palmer AJ, Valentine WJ, Chen R, Mehin N, Gabriel S, Bregman B, Rodby RA.

    Nephrol Dial Transplant. 2008 Apr;23(4):1216-23.PMID: 18359872 [PubMed - indexed for MEDLINE]Related articles

    3.

    Dialytic therapies to prevent NSF following gadolinium exposure in high-risk patients.

    Rodby RA.

    Semin Dial. 2008 Mar-Apr;21(2):145-9. Epub 2008 Jan 23. Review.PMID: 18226002 [PubMed - indexed for MEDLINE]Related articles

    4.

    Gadolinium-induced nephrogenic systemic fibrosis in patients with kidney disease.

    Perazella MA, Rodby RA.

    Am J Med. 2007 Jul;120(7):561-2. No abstract available. PMID: 17602923 [PubMed - indexed for MEDLINE]Related articles

    5.

    Gadolinium use in patients with kidney disease: a cause for concern.

    Perazella MA, Rodby RA.

    Semin Dial. 2007 May-Jun;20(3):179-85. Review.PMID: 17555477 [PubMed - indexed for MEDLINE]Related articles

    6.

    Preventing complications of radiographic contrast media: is there a role for dialysis?

    Rodby RA.

    Semin Dial. 2007 Jan-Feb;20(1):19-23. Review.PMID: 17244114 [PubMed - indexed for MEDLINE]Related articles

    7.

    A French cost-consequence analysis of the renoprotective benefits of irbesartan in patients with type 2 diabetes and hypertension.

    Palmer AJ, Valentine WJ, Tucker DM, Ray JA, Roze S, Annemans L, Lapuerta P, Chen R, Gabriel S, Carita P, Rodby RA, de Zeeuw D, Parving HH, Laville M.

    Curr Med Res Opin. 2006 Nov;22(11):2095-100.PMID: 17076969 [PubMed - indexed for MEDLINE]Related articles

    8.

    [Clinical and health economic implications of early treatment with irbesartan of patients with type 2 diabetes mellitus, hypertension and nephropathy]

    Palmer AJ, Roze S, Rodby RA, Valentine WJ, Ritz E, Lehnert H.

    Dtsch Med Wochenschr. 2006 Aug 4;131(31-32):1721-6. German. PMID: 16868875 [PubMed - indexed for MEDLINE]Related articles

    9.

    Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations.

    Pohl MA, Blumenthal S, Cordonnier DJ, De Alvaro F, Deferrari G, Eisner G, Esmatjes E, Gilbert RE, Hunsicker LG, de Faria JB, Mangili R, Moore J Jr, Reisin E, Ritz E, Schernthaner G, Spitalewitz S, Tindall H, Rodby RA, Lewis EJ.

    J Am Soc Nephrol. 2005 Oct;16(10):3027-37. Epub 2005 Aug 24.PMID: 16120823 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Irbesartan is projected to be cost and life saving in a Spanish setting for treatment of patients with type 2 diabetes, hypertension, and microalbuminuria.

    Palmer AJ, Annemans L, Roze S, Lapuerta P, Chen R, Gabriel S, Carita P, Rodby RA, de Zeeuw D, Parving HH, De Alvaro F.

    Kidney Int Suppl. 2005 Jan;(93):S52-4.PMID: 15613069 [PubMed - indexed for MEDLINE]Related articles

    11.

    Health economics studies assessing irbesartan use in patients with hypertension, type 2 diabetes, and microalbuminuria.

    Palmer AJ, Rodby RA.

    Kidney Int Suppl. 2004 Nov;(92):S118-20. Review.PMID: 15485404 [PubMed - indexed for MEDLINE]Related articles

    12.

    Pharmacoeconomic challenges in the management of diabetic nephropathy.

    Rodby RA.

    J Manag Care Pharm. 2004 Sep;10(5 Suppl A):S6-11.PMID: 15369419 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    [Cost-efectiveness of Ibersartan in type II diabetic nephropathy with hypertension. A Spanish perspective]

    Palmer AJ, Annemans L, Roze S, Lamotte M, Rodby RA, de Alvaro F; Grupo de Estudio Colaborativo IDNT.

    Nefrologia. 2004;24(3):231-8. Spanish. PMID: 15283313 [PubMed - indexed for MEDLINE]Related articles

    15.

    An economic evaluation of the Irbesartan in Diabetic Nephropathy Trial (IDNT) in a UK setting.

    Palmer AJ, Annemans L, Roze S, Lamotte M, Rodby RA, Bilous RW.

    J Hum Hypertens. 2004 Oct;18(10):733-8.PMID: 15116142 [PubMed - indexed for MEDLINE]Related articles

    17.

    [Health economic consequences of the use of irbesartan in patients in Germany with type 2 diabetes, nephropathy and hypertension]

    Palmer AJ, Annemans L, Roze S, Lamotte M, Rodby RA, Ritz E.

    Dtsch Med Wochenschr. 2004 Jan 2;129(1-2):13-8. German. PMID: 14703575 [PubMed - indexed for MEDLINE]Related articles

    19.

    The cost-effectiveness of irbesartan in the treatment of hypertensive patients with type 2 diabetic nephropathy.

    Rodby RA, Chiou CF, Borenstein J, Smitten A, Sengupta N, Palmer AJ, Roze S, Annemans L, Simon TA, Chen RS, Lewis EJ; Collaborative Study Group.

    Clin Ther. 2003 Jul;25(7):2102-19.PMID: 12946554 [PubMed - indexed for MEDLINE]Related articles

    20.

    Aliquot versus batch sampling methods for measurements of peritoneal dialysis adequacy in patients receiving CAPD.

    Rodby RA, Firanek CA.

    Perit Dial Int. 2003 Jan-Feb;23(1):87-9. No abstract available. PMID: 12691515 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    A clinical trial in type 2 diabetic nephropathy.

    Lewis EJ, Hunsicker LG, Rodby RA; Collaborative Study Group.

    Am J Kidney Dis. 2001 Oct;38(4 Suppl 1):S191-4.PMID: 11576953 [PubMed - indexed for MEDLINE]Related articles

    22.

    Re-evaluation of solute transport groups using the peritoneal equilibration test.

    Rodby RA, Firanek CA, Sarpolis AL.

    Perit Dial Int. 1999 Sep-Oct;19(5):438-41.PMID: 11379856 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    The Irbesartan type II diabetic nephropathy trial: study design and baseline patient characteristics. For the Collaborative Study Group.

    Rodby RA, Rohde RD, Clarke WR, Hunsicker LG, Anzalone DA, Atkins RC, Ritz E, Lewis EJ.

    Nephrol Dial Transplant. 2000 Apr;15(4):487-97.PMID: 10727543 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Hemofiltration for SIRS: bloodletting, twentieth century style?

    Rodby RA.

    Crit Care Med. 1998 Dec;26(12):1940-2. Review. No abstract available. PMID: 9875892 [PubMed - indexed for MEDLINE]Related articles

    25.

    Free pentosidine and neopterin as markers of progression rate in diabetic nephropathy. Collaborative Study Group.

    Weiss MF, Rodby RA, Justice AC, Hricik DE.

    Kidney Int. 1998 Jul;54(1):193-202.PMID: 9648079 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    An 18-year-old man with Goodpasture's syndrome and ANCA-negative central nervous system vasculitis.

    Rydel JJ, Rodby RA.

    Am J Kidney Dis. 1998 Feb;31(2):345-9.PMID: 9469509 [PubMed - indexed for MEDLINE]Related articles

    27.

    Antihypertensive treatment in nephropathy of type II diabetes: role of the pharmacological blockade of the renin-angiotensin system.

    Rodby RA.

    Nephrol Dial Transplant. 1997 Jun;12(6):1095-6. No abstract available. PMID: 9198032 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Type II diabetic nephropathy: its clinical course and therapeutic implications.

    Rodby RA.

    Semin Nephrol. 1997 Mar;17(2):132-47. Review.PMID: 9148379 [PubMed - indexed for MEDLINE]Related articles

    29.

    An economic analysis of captopril in the treatment of diabetic nephropathy. The Collaborative Study Group.

    Rodby RA, Firth LM, Lewis EJ.

    Diabetes Care. 1996 Oct;19(10):1051-61.PMID: 8886549 [PubMed - indexed for MEDLINE]Related articles

    30.

    ACE inhibition in diabetic patients. Economic implications.

    Rodby RA, Lewis EJ.

    Pharmacoeconomics. 1996 Oct;10(4):315-20. No abstract available. PMID: 10163576 [PubMed - indexed for MEDLINE]Related articles

    31.

    Reproducibility of studies of peritoneal dialysis adequacy.

    Rodby RA, Firanek CA, Cheng YG, Korbet SM.

    Kidney Int. 1996 Jul;50(1):267-71.PMID: 8807597 [PubMed - indexed for MEDLINE]Related articles

    32.

    The urine protein to creatinine ratio as a predictor of 24-hour urine protein excretion in type 1 diabetic patients with nephropathy. The Collaborative Study Group.

    Rodby RA, Rohde RD, Sharon Z, Pohl MA, Bain RP, Lewis EJ.

    Am J Kidney Dis. 1995 Dec;26(6):904-9.PMID: 7503064 [PubMed - indexed for MEDLINE]Related articles

    34.

    The use of continuous arteriovenous hemofiltration in orthotopic liver transplantation.

    Korbet SM, Casey C, Rodby RA, Williams W.

    Clin Nephrol. 1995 Feb;43(2):134-6. No abstract available. PMID: 7736677 [PubMed - indexed for MEDLINE]Related articles

    35.

    Nephrotic syndrome in a patient with unilateral renal dysplasia.

    Rodby RA, Schwartz MM.

    Am J Kidney Dis. 1995 Jan;25(1):88-95. Review. No abstract available. PMID: 7810541 [PubMed - indexed for MEDLINE]Related articles

    36.

    Abnormal acyltransferase activities and accelerated cholesteryl ester transfer in patients with nephrotic syndrome.

    Subbaiah PV, Rodby RA.

    Metabolism. 1994 Sep;43(9):1126-33.PMID: 8084287 [PubMed - indexed for MEDLINE]Related articles

    37.

    Rapid reversal of bone scan abnormalities in a patient with type 1 primary hyperoxaluria and oxalosis.

    Solmos GR, Ali A, Rodby RA, Fordham EW.

    Clin Nucl Med. 1994 Sep;19(9):769-72.PMID: 7982308 [PubMed - indexed for MEDLINE]Related articles

    38.

    Blood pressures in hemodialysis and peritoneal dialysis using ambulatory blood pressure monitoring.

    Rodby RA, Vonesh EF, Korbet SM.

    Am J Kidney Dis. 1994 Mar;23(3):401-11.PMID: 8128942 [PubMed - indexed for MEDLINE]Related articles

    39.

    Membranoproliferative glomerulonephritis associated with hepatitis C virus infection.

    Burstein DM, Rodby RA.

    J Am Soc Nephrol. 1993 Dec;4(6):1288-93.PMID: 7510533 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Proteinuria, hematuria, hypertension, and decreased renal function in a patient with diabetes for 9 years.

    Rodby RA, Schwartz MM.

    Am J Kidney Dis. 1992 Dec;20(6):658-67. No abstract available. PMID: 1463000 [PubMed - indexed for MEDLINE]Related articles

    42.

    Agrobacterium radiobacter peritonitis in two patients maintained on chronic peritoneal dialysis.

    Rodby RA, Glick EJ.

    Am J Kidney Dis. 1991 Sep;18(3):402-5.PMID: 1882836 [PubMed - indexed for MEDLINE]Related articles

    43.

    Renal transplant arterial thrombosis: association with cyclosporine.

    Dodhia N, Rodby RA, Jensik SC, Korbet SM.

    Am J Kidney Dis. 1991 May;17(5):532-6.PMID: 2024654 [PubMed - indexed for MEDLINE]Related articles

    44.

    Reversal of cardiac dysfunction secondary to type 1 primary hyperoxaluria after combined liver-kidney transplantation.

    Rodby RA, Tyszka TS, Williams JW.

    Am J Med. 1991 Apr;90(4):498-504.PMID: 2012090 [PubMed - indexed for MEDLINE]Related articles

    45.

    Baby poop peritonitis.

    Rodby RA.

    Perit Dial Int. 1990;10(1):99-100. No abstract available. PMID: 2085595 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Persistence of clinical and serologic activity in patients with systemic lupus erythematosus undergoing peritoneal dialysis.

    Rodby RA, Korbet SM, Lewis EJ.

    Am J Med. 1987 Oct;83(4):613-8.PMID: 3499820 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...